Pineapple, Inc. (PNPL)
Pineapple, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Los Angeles, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $51,172. On trailing twelve-month figures it carries a trailing P/E of -9.14, a net margin of -99.3%. Its beta of 3.44 implies it has historically moved more than the broad market.
Serving the cannabis industry, Pineapple, Inc. functions as a portfolio management firm. Its extensive asset portfolio encompasses a range of offerings, including operational guidance, technological support, intellectual property rights, and real estate rentals tailored for cannabis enterprises. The company also maintains equity investments in both retail and manufacturing segments of the cannabis market. Beyond these, Pineapple extends financing to its cannabis-focused clients, manages property leases for them, and delivers consulting services and technological expertise to facilitate the growth, enhancement, or establishment of new and existing business structures. Established in 1983, the firm's main offices are located in Los Angeles, California.
Pineapple, Inc. is most often compared with the following Healthcare names: